nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—ABCB1—Methylprednisolone—psoriatic arthritis	0.155	0.279	CbGbCtD
Naltrexone—ABCB1—Betamethasone—psoriatic arthritis	0.101	0.182	CbGbCtD
Naltrexone—ABCB1—Prednisolone—psoriatic arthritis	0.0996	0.179	CbGbCtD
Naltrexone—ABCB1—Prednisone—psoriatic arthritis	0.094	0.169	CbGbCtD
Naltrexone—ABCB1—Dexamethasone—psoriatic arthritis	0.0587	0.106	CbGbCtD
Naltrexone—ABCB1—Methotrexate—psoriatic arthritis	0.0472	0.0849	CbGbCtD
Naltrexone—Depression—Methotrexate—psoriatic arthritis	0.00061	0.00137	CcSEcCtD
Naltrexone—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000609	0.00137	CcSEcCtD
Naltrexone—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000609	0.00137	CcSEcCtD
Naltrexone—Discomfort—Triamcinolone—psoriatic arthritis	0.000609	0.00137	CcSEcCtD
Naltrexone—Discomfort—Methylprednisolone—psoriatic arthritis	0.000608	0.00137	CcSEcCtD
Naltrexone—Dry mouth—Triamcinolone—psoriatic arthritis	0.000603	0.00136	CcSEcCtD
Naltrexone—Angioedema—Betamethasone—psoriatic arthritis	0.0006	0.00135	CcSEcCtD
Naltrexone—Angioedema—Dexamethasone—psoriatic arthritis	0.0006	0.00135	CcSEcCtD
Naltrexone—Angiopathy—Prednisone—psoriatic arthritis	0.000596	0.00134	CcSEcCtD
Naltrexone—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000595	0.00134	CcSEcCtD
Naltrexone—Confusional state—Methylprednisolone—psoriatic arthritis	0.000594	0.00134	CcSEcCtD
Naltrexone—Immune system disorder—Prednisone—psoriatic arthritis	0.000594	0.00134	CcSEcCtD
Naltrexone—Malaise—Dexamethasone—psoriatic arthritis	0.000592	0.00133	CcSEcCtD
Naltrexone—Malaise—Betamethasone—psoriatic arthritis	0.000592	0.00133	CcSEcCtD
Naltrexone—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000591	0.00133	CcSEcCtD
Naltrexone—Oedema—Triamcinolone—psoriatic arthritis	0.000591	0.00133	CcSEcCtD
Naltrexone—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00059	0.00133	CcSEcCtD
Naltrexone—Syncope—Betamethasone—psoriatic arthritis	0.000589	0.00133	CcSEcCtD
Naltrexone—Syncope—Dexamethasone—psoriatic arthritis	0.000589	0.00133	CcSEcCtD
Naltrexone—Infection—Triamcinolone—psoriatic arthritis	0.000587	0.00132	CcSEcCtD
Naltrexone—Infection—Methylprednisolone—psoriatic arthritis	0.000586	0.00132	CcSEcCtD
Naltrexone—Shock—Triamcinolone—psoriatic arthritis	0.000581	0.00131	CcSEcCtD
Naltrexone—Insomnia—Prednisolone—psoriatic arthritis	0.000581	0.00131	CcSEcCtD
Naltrexone—Alopecia—Prednisone—psoriatic arthritis	0.000581	0.00131	CcSEcCtD
Naltrexone—Shock—Methylprednisolone—psoriatic arthritis	0.00058	0.00131	CcSEcCtD
Naltrexone—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000579	0.0013	CcSEcCtD
Naltrexone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000578	0.0013	CcSEcCtD
Naltrexone—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000577	0.0013	CcSEcCtD
Naltrexone—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000577	0.0013	CcSEcCtD
Naltrexone—Epistaxis—Methotrexate—psoriatic arthritis	0.000577	0.0013	CcSEcCtD
Naltrexone—Paraesthesia—Prednisolone—psoriatic arthritis	0.000577	0.0013	CcSEcCtD
Naltrexone—Tachycardia—Triamcinolone—psoriatic arthritis	0.000577	0.0013	CcSEcCtD
Naltrexone—Mental disorder—Prednisone—psoriatic arthritis	0.000576	0.0013	CcSEcCtD
Naltrexone—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000575	0.0013	CcSEcCtD
Naltrexone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000573	0.00129	CcSEcCtD
Naltrexone—Malnutrition—Prednisone—psoriatic arthritis	0.000572	0.00129	CcSEcCtD
Naltrexone—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000571	0.00129	CcSEcCtD
Naltrexone—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00057	0.00128	CcSEcCtD
Naltrexone—Convulsion—Betamethasone—psoriatic arthritis	0.000569	0.00128	CcSEcCtD
Naltrexone—Convulsion—Dexamethasone—psoriatic arthritis	0.000569	0.00128	CcSEcCtD
Naltrexone—Hypertension—Dexamethasone—psoriatic arthritis	0.000567	0.00128	CcSEcCtD
Naltrexone—Hypertension—Betamethasone—psoriatic arthritis	0.000567	0.00128	CcSEcCtD
Naltrexone—Myalgia—Betamethasone—psoriatic arthritis	0.000559	0.00126	CcSEcCtD
Naltrexone—Myalgia—Dexamethasone—psoriatic arthritis	0.000559	0.00126	CcSEcCtD
Naltrexone—Anxiety—Betamethasone—psoriatic arthritis	0.000557	0.00125	CcSEcCtD
Naltrexone—Anxiety—Dexamethasone—psoriatic arthritis	0.000557	0.00125	CcSEcCtD
Naltrexone—Discomfort—Betamethasone—psoriatic arthritis	0.000553	0.00124	CcSEcCtD
Naltrexone—Discomfort—Dexamethasone—psoriatic arthritis	0.000553	0.00124	CcSEcCtD
Naltrexone—Pain—Prednisolone—psoriatic arthritis	0.000549	0.00124	CcSEcCtD
Naltrexone—Hepatitis—Methotrexate—psoriatic arthritis	0.000549	0.00124	CcSEcCtD
Naltrexone—Pharyngitis—Methotrexate—psoriatic arthritis	0.000545	0.00123	CcSEcCtD
Naltrexone—Vision blurred—Prednisone—psoriatic arthritis	0.000539	0.00121	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000538	0.00121	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000537	0.00121	CcSEcCtD
Naltrexone—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000536	0.00121	CcSEcCtD
Naltrexone—Oedema—Betamethasone—psoriatic arthritis	0.000536	0.00121	CcSEcCtD
Naltrexone—Oedema—Dexamethasone—psoriatic arthritis	0.000536	0.00121	CcSEcCtD
Naltrexone—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000536	0.00121	CcSEcCtD
Naltrexone—Insomnia—Triamcinolone—psoriatic arthritis	0.000534	0.0012	CcSEcCtD
Naltrexone—Insomnia—Methylprednisolone—psoriatic arthritis	0.000533	0.0012	CcSEcCtD
Naltrexone—Infection—Dexamethasone—psoriatic arthritis	0.000533	0.0012	CcSEcCtD
Naltrexone—Infection—Betamethasone—psoriatic arthritis	0.000533	0.0012	CcSEcCtD
Naltrexone—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000531	0.00119	CcSEcCtD
Naltrexone—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000531	0.00119	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000529	0.00119	CcSEcCtD
Naltrexone—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000529	0.00119	CcSEcCtD
Naltrexone—Shock—Dexamethasone—psoriatic arthritis	0.000527	0.00119	CcSEcCtD
Naltrexone—Shock—Betamethasone—psoriatic arthritis	0.000527	0.00119	CcSEcCtD
Naltrexone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000527	0.00119	CcSEcCtD
Naltrexone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000526	0.00118	CcSEcCtD
Naltrexone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000526	0.00118	CcSEcCtD
Naltrexone—Agitation—Prednisone—psoriatic arthritis	0.000526	0.00118	CcSEcCtD
Naltrexone—Tachycardia—Betamethasone—psoriatic arthritis	0.000523	0.00118	CcSEcCtD
Naltrexone—Tachycardia—Dexamethasone—psoriatic arthritis	0.000523	0.00118	CcSEcCtD
Naltrexone—Angioedema—Prednisone—psoriatic arthritis	0.000523	0.00118	CcSEcCtD
Naltrexone—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000518	0.00117	CcSEcCtD
Naltrexone—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000518	0.00117	CcSEcCtD
Naltrexone—Malaise—Prednisone—psoriatic arthritis	0.000516	0.00116	CcSEcCtD
Naltrexone—Eye disorder—Methotrexate—psoriatic arthritis	0.000513	0.00116	CcSEcCtD
Naltrexone—Syncope—Prednisone—psoriatic arthritis	0.000513	0.00115	CcSEcCtD
Naltrexone—Tinnitus—Methotrexate—psoriatic arthritis	0.000512	0.00115	CcSEcCtD
Naltrexone—Anorexia—Dexamethasone—psoriatic arthritis	0.000511	0.00115	CcSEcCtD
Naltrexone—Anorexia—Betamethasone—psoriatic arthritis	0.000511	0.00115	CcSEcCtD
Naltrexone—Urticaria—Prednisolone—psoriatic arthritis	0.00051	0.00115	CcSEcCtD
Naltrexone—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00051	0.00115	CcSEcCtD
Naltrexone—Fatigue—Triamcinolone—psoriatic arthritis	0.000509	0.00115	CcSEcCtD
Naltrexone—Fatigue—Methylprednisolone—psoriatic arthritis	0.000508	0.00114	CcSEcCtD
Naltrexone—Pain—Triamcinolone—psoriatic arthritis	0.000505	0.00114	CcSEcCtD
Naltrexone—Loss of consciousness—Prednisone—psoriatic arthritis	0.000503	0.00113	CcSEcCtD
Naltrexone—Angiopathy—Methotrexate—psoriatic arthritis	0.000498	0.00112	CcSEcCtD
Naltrexone—Immune system disorder—Methotrexate—psoriatic arthritis	0.000496	0.00112	CcSEcCtD
Naltrexone—Convulsion—Prednisone—psoriatic arthritis	0.000496	0.00112	CcSEcCtD
Naltrexone—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000495	0.00111	CcSEcCtD
Naltrexone—Hypertension—Prednisone—psoriatic arthritis	0.000494	0.00111	CcSEcCtD
Naltrexone—Chills—Methotrexate—psoriatic arthritis	0.000493	0.00111	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000488	0.0011	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000488	0.0011	CcSEcCtD
Naltrexone—Arthralgia—Prednisone—psoriatic arthritis	0.000487	0.0011	CcSEcCtD
Naltrexone—Myalgia—Prednisone—psoriatic arthritis	0.000487	0.0011	CcSEcCtD
Naltrexone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000487	0.0011	CcSEcCtD
Naltrexone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000486	0.00109	CcSEcCtD
Naltrexone—Anxiety—Prednisone—psoriatic arthritis	0.000485	0.00109	CcSEcCtD
Naltrexone—Alopecia—Methotrexate—psoriatic arthritis	0.000485	0.00109	CcSEcCtD
Naltrexone—Insomnia—Dexamethasone—psoriatic arthritis	0.000485	0.00109	CcSEcCtD
Naltrexone—Insomnia—Betamethasone—psoriatic arthritis	0.000485	0.00109	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000484	0.00109	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000482	0.00109	CcSEcCtD
Naltrexone—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000481	0.00108	CcSEcCtD
Naltrexone—Paraesthesia—Betamethasone—psoriatic arthritis	0.000481	0.00108	CcSEcCtD
Naltrexone—Discomfort—Prednisone—psoriatic arthritis	0.000481	0.00108	CcSEcCtD
Naltrexone—Mental disorder—Methotrexate—psoriatic arthritis	0.000481	0.00108	CcSEcCtD
Naltrexone—Malnutrition—Methotrexate—psoriatic arthritis	0.000478	0.00108	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000473	0.00107	CcSEcCtD
Naltrexone—Urticaria—Triamcinolone—psoriatic arthritis	0.000469	0.00106	CcSEcCtD
Naltrexone—Urticaria—Methylprednisolone—psoriatic arthritis	0.000468	0.00105	CcSEcCtD
Naltrexone—Dysgeusia—Methotrexate—psoriatic arthritis	0.000468	0.00105	CcSEcCtD
Naltrexone—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000467	0.00105	CcSEcCtD
Naltrexone—Oedema—Prednisone—psoriatic arthritis	0.000467	0.00105	CcSEcCtD
Naltrexone—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000467	0.00105	CcSEcCtD
Naltrexone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000466	0.00105	CcSEcCtD
Naltrexone—Decreased appetite—Betamethasone—psoriatic arthritis	0.000466	0.00105	CcSEcCtD
Naltrexone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000466	0.00105	CcSEcCtD
Naltrexone—Infection—Prednisone—psoriatic arthritis	0.000464	0.00104	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000463	0.00104	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000463	0.00104	CcSEcCtD
Naltrexone—Back pain—Methotrexate—psoriatic arthritis	0.000462	0.00104	CcSEcCtD
Naltrexone—Fatigue—Dexamethasone—psoriatic arthritis	0.000462	0.00104	CcSEcCtD
Naltrexone—Fatigue—Betamethasone—psoriatic arthritis	0.000462	0.00104	CcSEcCtD
Naltrexone—Shock—Prednisone—psoriatic arthritis	0.000459	0.00103	CcSEcCtD
Naltrexone—Pain—Betamethasone—psoriatic arthritis	0.000458	0.00103	CcSEcCtD
Naltrexone—Pain—Dexamethasone—psoriatic arthritis	0.000458	0.00103	CcSEcCtD
Naltrexone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000458	0.00103	CcSEcCtD
Naltrexone—Tachycardia—Prednisone—psoriatic arthritis	0.000456	0.00103	CcSEcCtD
Naltrexone—Skin disorder—Prednisone—psoriatic arthritis	0.000453	0.00102	CcSEcCtD
Naltrexone—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000451	0.00102	CcSEcCtD
Naltrexone—Vision blurred—Methotrexate—psoriatic arthritis	0.000451	0.00101	CcSEcCtD
Naltrexone—Anorexia—Prednisone—psoriatic arthritis	0.000445	0.001	CcSEcCtD
Naltrexone—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000444	0.000998	CcSEcCtD
Naltrexone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000442	0.000994	CcSEcCtD
Naltrexone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000442	0.000994	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000438	0.000987	CcSEcCtD
Naltrexone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000438	0.000987	CcSEcCtD
Naltrexone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000435	0.00098	CcSEcCtD
Naltrexone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000434	0.000978	CcSEcCtD
Naltrexone—Malaise—Methotrexate—psoriatic arthritis	0.000431	0.00097	CcSEcCtD
Naltrexone—Urticaria—Dexamethasone—psoriatic arthritis	0.000426	0.000959	CcSEcCtD
Naltrexone—Urticaria—Betamethasone—psoriatic arthritis	0.000426	0.000959	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000425	0.000957	CcSEcCtD
Naltrexone—Dizziness—Prednisolone—psoriatic arthritis	0.000425	0.000956	CcSEcCtD
Naltrexone—Asthenia—Triamcinolone—psoriatic arthritis	0.000424	0.000954	CcSEcCtD
Naltrexone—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000424	0.000954	CcSEcCtD
Naltrexone—Body temperature increased—Betamethasone—psoriatic arthritis	0.000424	0.000954	CcSEcCtD
Naltrexone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000424	0.000954	CcSEcCtD
Naltrexone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000424	0.000954	CcSEcCtD
Naltrexone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000423	0.000952	CcSEcCtD
Naltrexone—Insomnia—Prednisone—psoriatic arthritis	0.000422	0.00095	CcSEcCtD
Naltrexone—Paraesthesia—Prednisone—psoriatic arthritis	0.000419	0.000944	CcSEcCtD
Naltrexone—Pruritus—Triamcinolone—psoriatic arthritis	0.000418	0.000941	CcSEcCtD
Naltrexone—Cough—Methotrexate—psoriatic arthritis	0.000417	0.000939	CcSEcCtD
Naltrexone—Pruritus—Methylprednisolone—psoriatic arthritis	0.000417	0.000939	CcSEcCtD
Naltrexone—Convulsion—Methotrexate—psoriatic arthritis	0.000414	0.000932	CcSEcCtD
Naltrexone—Arthralgia—Methotrexate—psoriatic arthritis	0.000407	0.000916	CcSEcCtD
Naltrexone—Chest pain—Methotrexate—psoriatic arthritis	0.000407	0.000916	CcSEcCtD
Naltrexone—Myalgia—Methotrexate—psoriatic arthritis	0.000407	0.000916	CcSEcCtD
Naltrexone—Decreased appetite—Prednisone—psoriatic arthritis	0.000406	0.000914	CcSEcCtD
Naltrexone—Rash—Prednisolone—psoriatic arthritis	0.000405	0.000912	CcSEcCtD
Naltrexone—Dermatitis—Prednisolone—psoriatic arthritis	0.000405	0.000911	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000404	0.00091	CcSEcCtD
Naltrexone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000403	0.000908	CcSEcCtD
Naltrexone—Fatigue—Prednisone—psoriatic arthritis	0.000403	0.000906	CcSEcCtD
Naltrexone—Headache—Prednisolone—psoriatic arthritis	0.000402	0.000906	CcSEcCtD
Naltrexone—Discomfort—Methotrexate—psoriatic arthritis	0.000402	0.000905	CcSEcCtD
Naltrexone—Constipation—Prednisone—psoriatic arthritis	0.000399	0.000899	CcSEcCtD
Naltrexone—Confusional state—Methotrexate—psoriatic arthritis	0.000393	0.000886	CcSEcCtD
Naltrexone—Dizziness—Triamcinolone—psoriatic arthritis	0.000391	0.000879	CcSEcCtD
Naltrexone—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00039	0.000878	CcSEcCtD
Naltrexone—Dizziness—Methylprednisolone—psoriatic arthritis	0.00039	0.000877	CcSEcCtD
Naltrexone—Infection—Methotrexate—psoriatic arthritis	0.000388	0.000873	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisone—psoriatic arthritis	0.000385	0.000866	CcSEcCtD
Naltrexone—Asthenia—Betamethasone—psoriatic arthritis	0.000385	0.000866	CcSEcCtD
Naltrexone—Asthenia—Dexamethasone—psoriatic arthritis	0.000385	0.000866	CcSEcCtD
Naltrexone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000383	0.000861	CcSEcCtD
Naltrexone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000382	0.000859	CcSEcCtD
Naltrexone—Nausea—Prednisolone—psoriatic arthritis	0.000382	0.000859	CcSEcCtD
Naltrexone—Pruritus—Betamethasone—psoriatic arthritis	0.000379	0.000854	CcSEcCtD
Naltrexone—Pruritus—Dexamethasone—psoriatic arthritis	0.000379	0.000854	CcSEcCtD
Naltrexone—Skin disorder—Methotrexate—psoriatic arthritis	0.000379	0.000853	CcSEcCtD
Naltrexone—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000377	0.000849	CcSEcCtD
Naltrexone—Vomiting—Triamcinolone—psoriatic arthritis	0.000376	0.000846	CcSEcCtD
Naltrexone—Vomiting—Methylprednisolone—psoriatic arthritis	0.000375	0.000844	CcSEcCtD
Naltrexone—Rash—Triamcinolone—psoriatic arthritis	0.000373	0.000839	CcSEcCtD
Naltrexone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000372	0.000838	CcSEcCtD
Naltrexone—Anorexia—Methotrexate—psoriatic arthritis	0.000372	0.000837	CcSEcCtD
Naltrexone—Rash—Methylprednisolone—psoriatic arthritis	0.000372	0.000837	CcSEcCtD
Naltrexone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000371	0.000836	CcSEcCtD
Naltrexone—Urticaria—Prednisone—psoriatic arthritis	0.000371	0.000835	CcSEcCtD
Naltrexone—Headache—Triamcinolone—psoriatic arthritis	0.00037	0.000833	CcSEcCtD
Naltrexone—Headache—Methylprednisolone—psoriatic arthritis	0.000369	0.000831	CcSEcCtD
Naltrexone—Abdominal pain—Prednisone—psoriatic arthritis	0.000369	0.000831	CcSEcCtD
Naltrexone—Body temperature increased—Prednisone—psoriatic arthritis	0.000369	0.000831	CcSEcCtD
Naltrexone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000367	0.000826	CcSEcCtD
Naltrexone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000367	0.000826	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000355	0.0008	CcSEcCtD
Naltrexone—Dizziness—Betamethasone—psoriatic arthritis	0.000355	0.000798	CcSEcCtD
Naltrexone—Dizziness—Dexamethasone—psoriatic arthritis	0.000355	0.000798	CcSEcCtD
Naltrexone—Insomnia—Methotrexate—psoriatic arthritis	0.000353	0.000794	CcSEcCtD
Naltrexone—Nausea—Triamcinolone—psoriatic arthritis	0.000351	0.00079	CcSEcCtD
Naltrexone—Paraesthesia—Methotrexate—psoriatic arthritis	0.00035	0.000789	CcSEcCtD
Naltrexone—Nausea—Methylprednisolone—psoriatic arthritis	0.00035	0.000788	CcSEcCtD
Naltrexone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000348	0.000783	CcSEcCtD
Naltrexone—Somnolence—Methotrexate—psoriatic arthritis	0.000347	0.000781	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisone—psoriatic arthritis	0.000344	0.000774	CcSEcCtD
Naltrexone—Vomiting—Betamethasone—psoriatic arthritis	0.000341	0.000767	CcSEcCtD
Naltrexone—Vomiting—Dexamethasone—psoriatic arthritis	0.000341	0.000767	CcSEcCtD
Naltrexone—Decreased appetite—Methotrexate—psoriatic arthritis	0.000339	0.000763	CcSEcCtD
Naltrexone—Rash—Betamethasone—psoriatic arthritis	0.000338	0.000761	CcSEcCtD
Naltrexone—Rash—Dexamethasone—psoriatic arthritis	0.000338	0.000761	CcSEcCtD
Naltrexone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000338	0.00076	CcSEcCtD
Naltrexone—Dermatitis—Betamethasone—psoriatic arthritis	0.000338	0.00076	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000337	0.000758	CcSEcCtD
Naltrexone—Fatigue—Methotrexate—psoriatic arthritis	0.000336	0.000757	CcSEcCtD
Naltrexone—Headache—Dexamethasone—psoriatic arthritis	0.000336	0.000756	CcSEcCtD
Naltrexone—Headache—Betamethasone—psoriatic arthritis	0.000336	0.000756	CcSEcCtD
Naltrexone—Asthenia—Prednisone—psoriatic arthritis	0.000335	0.000754	CcSEcCtD
Naltrexone—Pain—Methotrexate—psoriatic arthritis	0.000334	0.000751	CcSEcCtD
Naltrexone—Pruritus—Prednisone—psoriatic arthritis	0.00033	0.000743	CcSEcCtD
Naltrexone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000322	0.000724	CcSEcCtD
Naltrexone—Diarrhoea—Prednisone—psoriatic arthritis	0.000319	0.000719	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000319	0.000718	CcSEcCtD
Naltrexone—Nausea—Betamethasone—psoriatic arthritis	0.000318	0.000717	CcSEcCtD
Naltrexone—Nausea—Dexamethasone—psoriatic arthritis	0.000318	0.000717	CcSEcCtD
Naltrexone—Urticaria—Methotrexate—psoriatic arthritis	0.00031	0.000698	CcSEcCtD
Naltrexone—Dizziness—Prednisone—psoriatic arthritis	0.000309	0.000695	CcSEcCtD
Naltrexone—Body temperature increased—Methotrexate—psoriatic arthritis	0.000308	0.000694	CcSEcCtD
Naltrexone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000308	0.000694	CcSEcCtD
Naltrexone—Vomiting—Prednisone—psoriatic arthritis	0.000297	0.000668	CcSEcCtD
Naltrexone—Rash—Prednisone—psoriatic arthritis	0.000294	0.000663	CcSEcCtD
Naltrexone—Dermatitis—Prednisone—psoriatic arthritis	0.000294	0.000662	CcSEcCtD
Naltrexone—Headache—Prednisone—psoriatic arthritis	0.000292	0.000658	CcSEcCtD
Naltrexone—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000287	0.000647	CcSEcCtD
Naltrexone—Asthenia—Methotrexate—psoriatic arthritis	0.00028	0.00063	CcSEcCtD
Naltrexone—Nausea—Prednisone—psoriatic arthritis	0.000277	0.000624	CcSEcCtD
Naltrexone—Pruritus—Methotrexate—psoriatic arthritis	0.000276	0.000621	CcSEcCtD
Naltrexone—Diarrhoea—Methotrexate—psoriatic arthritis	0.000267	0.000601	CcSEcCtD
Naltrexone—Dizziness—Methotrexate—psoriatic arthritis	0.000258	0.000581	CcSEcCtD
Naltrexone—Vomiting—Methotrexate—psoriatic arthritis	0.000248	0.000558	CcSEcCtD
Naltrexone—Rash—Methotrexate—psoriatic arthritis	0.000246	0.000554	CcSEcCtD
Naltrexone—Dermatitis—Methotrexate—psoriatic arthritis	0.000246	0.000553	CcSEcCtD
Naltrexone—Headache—Methotrexate—psoriatic arthritis	0.000244	0.00055	CcSEcCtD
Naltrexone—Nausea—Methotrexate—psoriatic arthritis	0.000232	0.000522	CcSEcCtD
